Table 3 Clinical Characteristics of the Three Groups with Comorbidities
Total (n = 54) | UV (n = 22) | PV (n = 13) | FV (n = 19) | P | |
|---|---|---|---|---|---|
Gender | 0.573 | ||||
Male, No. (%) | 24 (44.4) | 8 (36.4) | 7 (53.8) | 9 (47.4) | |
Female, No. (%) | 30 (55.6) | 14 (63.6) | 6 (46.2) | 10 (52.6) | |
Age, years | 61.11 ± 12.41 | 63.05 ± 15.43 | 64.92 ± 10.75 | 56.26 ± 7.67 | 0.096 |
BMI, kg/m2 | 23.21 (21.96–25.56) | 23.34 (20.88–25.86) | 22.72 (22.1–25.27) | 23.53 (22.23–25.35) | 0.705 |
Current Smoking, No. (%) | 24 (60) | 9 (56.3) | 7 (70) | 8 (57.1) | 0.734 |
Symptoms | |||||
Fever, No. (%) | 14 (35) | 3 (18.8) | 3 (30) | 8 (57.1) | 0.112 |
Cough, No. (%) | 21 (52.5) | 11 (68.8) | 3 (30) | 7 (50) | 0.28 |
Diarrhea, No. (%) | 3 (7.5) | 1 (6.3) | 1 (10) | 1 (7.1) | |
Sore throat, No. (%) | 5 (12.5) | 1 (6.3) | 1 (10) | 3 (21.4) | |
Abdominal pain, No. (%) | 1 (2.5) | 1 (6.3) | 0 | 0 | |
Loss of smell, No. (%) | 2 (5) | 0 | 1 (10) | 1 (7.1) | |
Muscle pains, No. (%) | 2 (5) | 2 (12.5) | 0 | 0 (0) | |
Dizziness, No. (%) | 1 (2.5) | 1 (6.3) | 0 | 0 (0) | |
Fatigue, No. (%) | 7 (17.5) | 4 (25) | 2 (20) | 1 (7.1) | |
Stuffy nose, No. (%) | 4 (10) | 3 (18.8) | 0 | 1 (7.1) | |
Runny nose, No. (%) | 2 (5) | 1 (6.3) | 1 (10) | 0 | |
Headache, No. (%) | 2 (5) | 1 (6.3) | 1 (10) | 0 | |
Asymptomatic, No. (%) | 6 (15) | 4 (25) | 1 (10) | 1 (7.1) | |
Complications | |||||
Liver dysfunction, No. (%) | 25 (46.3) | 12 (54.5) | 5 (38.5) | 8 (42.1) | 0.589 |
Renal dysfunction, No. (%) | 26 (48.1) | 9 (40.9) | 6 (46.2) | 11 (57.9) | 0.547 |
Treatment | |||||
Thymosin α1, No. (%) | 9 (16.7) | 4 (18.2) | 1 (7.7) | 4 (21.1) | 0.591 |
Days from illness onset to hospital admission | 2 (1–4) | 2 (1–3) | 4 (1.5–6) | 2 (2–3) | 0.060 |
Ct value | 29.12 ± 5.65 | 28.77 ± 5.5 | 30.37 ± 7.26 | 28.68 ± 4.68 | 0.665 |